Back to search
FDAFDA · Food and drugs·Recall number D-0178-2026

Fentanyl citrate, 2 mcg / ml / Ropivacaine, 0.2% in NS 150 mL, CII, 150 mL bag, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110, NDC 83863-4272-1.

Published November 26, 2025 · Recall initiated: September 23, 2025

Summary

FDA records drug Class II recall D-0178-2026, published November 26, 2025 and initiated September 23, 2025. Recalling firm: Park Avenue Compounding; Status: Ongoing; Reported quantity: 189 bags; Lot: Lot # 20250507-01D93C, Exp Date: 11-04-2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Park Avenue Compounding
Distributor
Distributed in Missouri
Lot
Lot # 20250507-01D93C, Exp Date: 11-04-2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fentanyl citrate, 2 mcg / ml / Ropivacaine, 0.2% in NS 150 mL, CII, 150 mL bag, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110, NDC 83863-4272-1. recalled?

Yes. FDA published recall D-0178-2026 on November 26, 2025. Reported hazard: CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.

What should I do if I have this product?

Voluntary: Firm initiated · Letter